ELAD

BIOLOGICAL3 trials

Sponsors

Vital Therapies, Inc.

Conditions

Acute Liver FailureFulminant Hepatic FailurePrimary Graft Non-FunctionSevere Acute Alcoholic HepatitisSurgically-Induced Liver Failure

Phase 2

Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure

CompletedNCT00030225

Vital Therapies, Inc.Fulminant Hepatic Failure

Start: 2002-01-31End: 2003-02-28Updated: 2012-07-26

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

TerminatedNCT01875874

Vital Therapies, Inc.Acute Liver Failure, Fulminant Hepatic Failure, Primary Graft Non-Function +1

Start: 2014-10-31End: 2018-09-30Updated: 2019-02-12

Phase 3

To Assess Safety/Efficacy of ELAD in Subjects w/ Severe Acute Alcoholic Hepatitis (sAAH) and Lille Score Failure

TerminatedNCT01829347

Vital Therapies, Inc.Severe Acute Alcoholic Hepatitis

Start: 2014-04-30End: 2018-09-30Updated: 2019-02-19